Literature DB >> 16228830

Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a case.

Robert Finch1, Harvey G Moore, Noralane Lindor, Syed M Jalal, Arnold Markowitz, Jhanwar Suresh, Kenneth Offit, Jose G Guillem.   

Abstract

Familial adenomatous polyposis, caused by mutations in the adenomatous polyposis coli gene located at chromosome 5q21, is an autosomal dominant syndrome characterized by polyposis of the colon and rectum and nearly 100 percent progression to colorectal cancer. We report a case of familial adenomatous polyposis and mental retardation caused by a chromosomal deletion at 5q15-q22. Chromosomal analysis is considered part of the evaluation of children with mental retardation and developmental delay. The resulting karyotypes from high-resolution chromosomal analysis can help characterize large deletions, some of which involve known tumor suppressor genes. Because familial adenomatous polyposis may arise from de novo chromosomal deletions involving the adenomatous polyposis coli gene locus, individuals with chromosomal deletions involving 5q21 should be considered at-risk for familial adenomatous polyposis and offered standard screening with flexible sigmoidoscopy by 10 to 12 years of age.

Entities:  

Mesh:

Year:  2005        PMID: 16228830     DOI: 10.1007/s10350-005-0177-7

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

1.  Adenomatous polyposis coli protein deletion leads to cognitive and autism-like disabilities.

Authors:  J L Mohn; J Alexander; A Pirone; C D Palka; S-Y Lee; L Mebane; P G Haydon; M H Jacob
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

2.  Adenomatous polyposis coli plays a key role, in vivo, in coordinating assembly of the neuronal nicotinic postsynaptic complex.

Authors:  Madelaine M Rosenberg; Fang Yang; Monica Giovanni; Jesse L Mohn; Murali K Temburni; Michele H Jacob
Journal:  Mol Cell Neurosci       Date:  2008-03-04       Impact factor: 4.314

3.  Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.

Authors:  Seyed Ali Hosseini; Susan Horton; Joshua C Saldivar; Satoshi Miuma; Martha R Stampfer; Nyla A Heerema; Kay Huebner
Journal:  Genes Chromosomes Cancer       Date:  2013-08-09       Impact factor: 5.006

4.  Differences in neuropsychological and behavioral parameters and brain structure in patients with familial adenomatous polyposis: a sibling-paired study.

Authors:  Ana Sánchez Azofra; Trilokesh D Kidambi; Rita J Jeremy; Peggy Conrad; Amie Blanco; Megan Myers; James Barkovich; Jonathan P Terdiman
Journal:  Hered Cancer Clin Pract       Date:  2016-10-10       Impact factor: 2.857

5.  Ubiquitous neurocognitive dysfunction in familial adenomatous polyposis: proof-of-concept of the role of APC protein in neurocognitive function.

Authors:  Marcia Roxana Cruz-Correa; Ana Cecilia Sala; Beatriz Cintrón; Jessica Hernández; Myrta Olivera; Adrian Cora; Constance M Moore; Carlos A Luciano; Marievelisse Soto-Salgado; Francis M Giardiello; Stephen R Hooper
Journal:  Hered Cancer Clin Pract       Date:  2020-02-24       Impact factor: 2.857

6.  A novel SYBR-based duplex qPCR for the detection of gene dosage: detection of an APC large deletion in a familial adenomatous polyposis patient with an unusual phenotype.

Authors:  Giovana Tardin Torrezan; Felipe Cavalcanti Carneiro da Silva; Ana Cristina Victorino Krepischi; Erika Maria Monteiro dos Santos; Benedito Mauro Rossi; Dirce Maria Carraro
Journal:  BMC Med Genet       Date:  2012-07-16       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.